Anoxia/reoxygenation injury in hepatocytes is not prevented by calcium channel blockers.
Gasbarrini
A
A
Department of Surgery, University of Pittsburgh, Pennsylvania.
Borle
A B
AB
Caraceni
P
P
Farghali
H
H
Azzarone
A
A
Fagiuoli
S
S
Starzl
T E
TE
Van Thiel
D H
DH
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015687:Cell Hypoxia / Q000187:drug effects*; D002478:Cells, Cultured; D003470:Culture Media; D004110:Diltiazem / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008099:Liver / Q000166:cytology*; D008297:Male; D009543:Nifedipine / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D003470:Culture Media; D014700:Verapamil; D007770:L-Lactate Dehydrogenase; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium